Cannabis stocks were mostly lower on Tuesday, led by Curaleaf Holdings after the U.S. Food and Drug Administration sent a warning letter to the company for claiming CBD-based products could treat a range of serious diseases, including Alzheimer’s disease. Read More...
Cannabis stocks slammed after FDA warning to Curaleaf for CBD claims
Cannabis stocks were mostly lower on Tuesday, led by Curaleaf Holdings after the U.S. Food and Drug Administration sent a warning letter to the company for claiming CBD-based products could treat a range of serious diseases, including Alzheimer’s disease.
